Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: TRI-PHARMA, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-02-23 to 2023-06-23
Current total value of award: $23952
Description: TRI-PHARMA, INC.:1307949 [23-004870] FLUDARABINE